IDS-NM-009 |
INFUMORPH |
AVINZA |
N02AA01 |
KADIAN |
MORPHINE |
DEPODUR |
ANHYDROUS MORPHINE |
(5Α,6Α)-DIDEHYDRO-4,5-EPOXY-17-METHYLMORPHINAN-3,6-DIOL |
(5Α,6Α)-17-METHYL-7,8-DIDEHYDRO-4,5-EPOXYMORPHINAN-3,6-DIOL |
(5R,6S,9R,13S,14R)-4,5-EPOXY-N-METHYL-7-MORPHINEN-3,6-DIOL |
MORPHINE SULFATE |
ORAMORPH® |
(5ALPHA,6ALPHA)-17-METHYL-7,8-DIDEHYDRO-4,5-EPOXYMORPHINAN-3,6-DIOL |
(7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL |
MORPHINUM |
MORPHIUM |
MORPHIN |
(-)-MORPHINE |
(5ALPHA,6ALPHA)-DIDEHYDRO-4,5-EPOXY-17-METHYLMORPHINAN-3,6-DIOL |
MORFINA |
MORPHIA |
(−)-MORPHINE |
MS CONTIN® |
chembl:CHEMBL70 |
pubchem.compound:5288826 |
rxcui:7052 |
chemidplus:57-27-2 |
drugbank:00295 |
Year of Approval | approved before 1982 |
Drug Class | analgesics, opioid |
Drug Categories | phenanthrenes |
Drug Class | Small molecule |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | analgesic |
Drug Categories | anesthetics |
Drug Categories | cytochrome p-450 cyp3a substrates |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | heterocyclic compounds, fused-ring |
Drug Categories | high-risk opioids |
Drug Categories | natural opium alkaloids |
Drug Categories | neuraxial anesthetics |
Drug Categories | opiate agonists |
Drug Categories | opioid agonist |
Drug Categories | opioids |
Drug Categories | p-glycoprotein substrates |
Drug Categories | serotonergic drugs shown to increase risk of serotonin syndrome |
Drug Categories | ugt1a1 substrates |
Drug Categories | ugt1a3 substrates |
Drug Categories | ugt2b7 substrates |
agonist (activating) |
Specific Action of the Ligand | Full agonist |
Endogenous Drug? | False |
Trial Name | ALO-01, morphine sulfate and naltrexone hydrochloride,Embeda, Kadian NT |
agonist (activating) |
Trial Name | ALO-01, morphine sulfate and naltrexone hydrochloride,Embeda, Kadian NT |
Novel drug target | Established target |
Trial Name | intranasal morphine,Rylomine |
57-27-2 | CAS Number |
Arymo ER | Drug Brand |
Astramorph | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Groups | investigational |
Drug Class | analgesics, opioid |
Year of Approval | approved before 1982 |
Drug Indications | analgesic |
Drug Class | Small Molecule |
FDA Approval | approved |
CHEMBL70 | ChEMBL Drug ID |
C669 | NCI drug code |
D0WE3O | TTD Drug ID |